Tech Company Inital Public Offerings
NeuroPace IPO
Operating out of Mountain View, NeuroPace went public.
Transaction Overview
Company Name
Announced On
4/22/2021
Transaction Type
IPO
Amount
$90,100,000
Proceeds Purpose
Use of proceeds for the NeuroPace IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
455 N. Bernardo Ave.
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Website
Email Address
Overview
NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Favet
Chief Financial Officer
Rebecca Kuhn
Chief Medical Officer
Martha Morrell
VP - General Counsel
Pamela Maher
VP - Human Resources
Irene Thomas
VP - Marketing
Chi Nguyen
VP - Regulatory Affairs
Isabella Abati
VP - Sales
Mark Saxton
Browse more venture capital transactions:
Prev: 4/22/2021: RapidAPI venture capital transaction
Next: 4/22/2021: Hive venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs